Annual Retained Earnings
-$1.51 B
+$12.67 M+0.83%
December 31, 2023
Summary
- As of February 8, 2025, TGTX annual retained earnings is -$1.51 billion, with the most recent change of +$12.67 million (+0.83%) on December 31, 2023.
- During the last 3 years, TGTX annual retained earnings has fallen by -$533.76 million (-54.43%).
- TGTX annual retained earnings is now -177412.72% below its all-time high of -$853.10 thousand, reached on December 31, 2011.
Performance
TGTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.55 B
+$3.88 M+0.25%
September 30, 2024
Summary
- As of February 8, 2025, TGTX quarterly retained earnings is -$1.55 billion, with the most recent change of +$3.88 million (+0.25%) on September 30, 2024.
- Over the past year, TGTX quarterly retained earnings has dropped by -$27.46 million (-1.80%).
- TGTX quarterly retained earnings is now -181886.29% below its all-time high of -$853.10 thousand, reached on December 31, 2011.
Performance
TGTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TGTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | -1.8% |
| 3 y3 years | -54.4% | +3.8% |
| 5 y5 years | -186.6% | +3.8% |
TGTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.0% | +0.8% | -16.9% | +3.8% |
| 5 y | 5-year | -116.0% | +0.8% | -121.4% | +3.8% |
| alltime | all time | <-9999.0% | +0.8% | <-9999.0% | +3.8% |
TG Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.55 B(-0.2%) |
| Jun 2024 | - | -$1.56 B(+2.1%) |
| Mar 2024 | - | -$1.53 B(+0.7%) |
| Dec 2023 | -$1.51 B(-0.8%) | -$1.51 B(+1.0%) |
| Sep 2023 | - | -$1.50 B(-7.1%) |
| Jun 2023 | - | -$1.61 B(+3.0%) |
| Mar 2023 | - | -$1.57 B(+2.6%) |
| Dec 2022 | -$1.53 B(+14.9%) | -$1.53 B(+3.6%) |
| Sep 2022 | - | -$1.47 B(+2.5%) |
| Jun 2022 | - | -$1.44 B(+2.9%) |
| Mar 2022 | - | -$1.40 B(+5.2%) |
| Dec 2021 | -$1.33 B(+35.5%) | -$1.33 B(+7.6%) |
| Sep 2021 | - | -$1.24 B(+7.4%) |
| Jun 2021 | - | -$1.15 B(+7.3%) |
| Mar 2021 | - | -$1.07 B(+9.2%) |
| Dec 2020 | -$980.60 M(+39.8%) | -$980.60 M(+9.9%) |
| Sep 2020 | - | -$892.38 M(+10.8%) |
| Jun 2020 | - | -$805.22 M(+7.0%) |
| Mar 2020 | - | -$752.33 M(+7.3%) |
| Dec 2019 | -$701.22 M(+32.7%) | -$701.22 M(+6.0%) |
| Sep 2019 | - | -$661.64 M(+10.3%) |
| Jun 2019 | - | -$599.71 M(+6.4%) |
| Mar 2019 | - | -$563.50 M(+6.7%) |
| Dec 2018 | -$528.35 M(+48.9%) | -$528.35 M(+11.4%) |
| Sep 2018 | - | -$474.49 M(+7.7%) |
| Jun 2018 | - | -$440.53 M(+11.1%) |
| Mar 2018 | - | -$396.39 M(+11.7%) |
| Dec 2017 | -$354.86 M(+50.1%) | -$354.86 M(+9.5%) |
| Sep 2017 | - | -$324.00 M(+10.8%) |
| Jun 2017 | - | -$292.47 M(+10.7%) |
| Mar 2017 | - | -$264.11 M(+11.7%) |
| Dec 2016 | -$236.39 M(+49.5%) | -$236.39 M(+11.1%) |
| Sep 2016 | - | -$212.71 M(+13.2%) |
| Jun 2016 | - | -$187.88 M(+9.2%) |
| Mar 2016 | - | -$171.98 M(+8.8%) |
| Dec 2015 | -$158.13 M(+66.1%) | -$158.13 M(+12.5%) |
| Sep 2015 | - | -$140.52 M(+10.8%) |
| Jun 2015 | - | -$126.87 M(+15.6%) |
| Mar 2015 | - | -$109.76 M(+15.3%) |
| Dec 2014 | -$95.19 M(+141.6%) | -$95.19 M(+24.6%) |
| Sep 2014 | - | -$76.39 M(+29.6%) |
| Jun 2014 | - | -$58.94 M(+25.5%) |
| Mar 2014 | - | -$46.95 M(+19.2%) |
| Dec 2013 | -$39.40 M(+108.2%) | -$39.40 M(+16.8%) |
| Sep 2013 | - | -$33.74 M(+15.6%) |
| Jun 2013 | - | -$29.18 M(+29.1%) |
| Mar 2013 | - | -$22.60 M(+19.4%) |
| Dec 2012 | -$18.93 M(+2118.5%) | -$18.93 M(+22.4%) |
| Sep 2012 | - | -$15.47 M(+18.9%) |
| Jun 2012 | - | -$13.00 M(+17.1%) |
| Mar 2012 | - | -$11.11 M(+1202.2%) |
| Dec 2011 | -$853.10 K(-98.6%) | -$853.10 K(-98.6%) |
| Sep 2011 | - | -$61.01 M(+0.9%) |
| Jun 2011 | - | -$60.46 M(+5.2%) |
| Mar 2011 | - | -$57.48 M(-6.3%) |
| Dec 2010 | -$61.31 M | -$61.31 M(-0.6%) |
| Sep 2010 | - | -$61.67 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -$61.72 M(-2.9%) |
| Mar 2010 | - | -$63.57 M(+2.6%) |
| Dec 2009 | -$61.93 M(+4.5%) | -$61.93 M(+0.4%) |
| Sep 2009 | - | -$61.71 M(+0.7%) |
| Jun 2009 | - | -$61.29 M(+2.3%) |
| Mar 2009 | - | -$59.90 M(+1.1%) |
| Dec 2008 | -$59.27 M(+7.8%) | -$59.27 M(-0.2%) |
| Sep 2008 | - | -$59.39 M(+2.4%) |
| Jun 2008 | - | -$58.00 M(+2.5%) |
| Mar 2008 | - | -$56.56 M(+2.8%) |
| Dec 2007 | -$55.00 M(+28.0%) | -$55.00 M(+3.6%) |
| Sep 2007 | - | -$53.09 M(+5.3%) |
| Jun 2007 | - | -$50.43 M(+10.7%) |
| Mar 2007 | - | -$45.53 M(+6.0%) |
| Dec 2006 | -$42.97 M(+29.1%) | -$42.97 M(+7.9%) |
| Sep 2006 | - | -$39.84 M(+5.0%) |
| Jun 2006 | - | -$37.94 M(+5.1%) |
| Mar 2006 | - | -$36.09 M(+8.5%) |
| Dec 2005 | -$33.27 M(+138.4%) | -$33.27 M(+7.7%) |
| Sep 2005 | - | -$30.88 M(+6.5%) |
| Jun 2005 | - | -$28.99 M(+87.0%) |
| Mar 2005 | - | -$15.51 M(+11.1%) |
| Dec 2004 | -$13.96 M(+86.7%) | -$13.96 M(+15.1%) |
| Sep 2004 | - | -$12.12 M(+23.4%) |
| Jun 2004 | - | -$9.82 M(+11.9%) |
| Mar 2004 | - | -$8.78 M(+17.5%) |
| Dec 2003 | -$7.47 M(+583.0%) | -$7.47 M(+34.8%) |
| Sep 2003 | - | -$5.55 M(+141.9%) |
| Jun 2003 | - | -$2.29 M(+51.2%) |
| Mar 2003 | - | -$1.52 M(+38.6%) |
| Dec 2002 | -$1.09 M(-95.9%) | -$1.09 M(-96.1%) |
| Sep 2002 | - | -$27.90 M(+2.1%) |
| Jun 2002 | - | -$27.32 M(-0.1%) |
| Mar 2002 | - | -$27.35 M(+2.3%) |
| Dec 2001 | -$26.73 M(+7.7%) | -$26.73 M(+2.2%) |
| Sep 2001 | - | -$26.16 M(+2.9%) |
| Jun 2001 | - | -$25.43 M(+9.1%) |
| Mar 2001 | - | -$23.31 M(-6.1%) |
| Dec 2000 | -$24.83 M(+32.1%) | -$24.83 M(+2.5%) |
| Sep 2000 | - | -$24.23 M(+4.2%) |
| Jun 2000 | - | -$23.26 M(+15.3%) |
| Mar 2000 | - | -$20.17 M(+7.3%) |
| Dec 1999 | -$18.80 M(+15.3%) | -$18.80 M(+3.3%) |
| Sep 1999 | - | -$18.20 M(+1.7%) |
| Jun 1999 | - | -$17.90 M(+4.1%) |
| Mar 1999 | - | -$17.20 M(+5.5%) |
| Dec 1998 | -$16.30 M(+20.7%) | -$16.30 M(+7.9%) |
| Sep 1998 | - | -$15.10 M(+9.4%) |
| Jun 1998 | - | -$13.80 M(-7.4%) |
| Mar 1998 | - | -$14.90 M(+10.4%) |
| Dec 1997 | -$13.50 M(+60.7%) | -$13.50 M(+11.6%) |
| Sep 1997 | - | -$12.10 M(+7.1%) |
| Jun 1997 | - | -$11.30 M(+20.2%) |
| Mar 1997 | - | -$9.40 M(+11.9%) |
| Dec 1996 | -$8.40 M | -$8.40 M(+12.0%) |
| Sep 1996 | - | -$7.50 M(+17.2%) |
| Jun 1996 | - | -$6.40 M |
FAQ
- What is TG Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for TG Therapeutics?
- What is TG Therapeutics annual retained earnings year-on-year change?
- What is TG Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for TG Therapeutics?
- What is TG Therapeutics quarterly retained earnings year-on-year change?
What is TG Therapeutics annual retained earnings?
The current annual retained earnings of TGTX is -$1.51 B
What is the all time high annual retained earnings for TG Therapeutics?
TG Therapeutics all-time high annual retained earnings is -$853.10 K
What is TG Therapeutics annual retained earnings year-on-year change?
Over the past year, TGTX annual retained earnings has changed by +$12.67 M (+0.83%)
What is TG Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TGTX is -$1.55 B
What is the all time high quarterly retained earnings for TG Therapeutics?
TG Therapeutics all-time high quarterly retained earnings is -$853.10 K
What is TG Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TGTX quarterly retained earnings has changed by -$27.46 M (-1.80%)